They can be Osprey's figures. At $350USD per unit, Osprey would need DyeVert to be used in just over 2.85 million procedures a year for $1 billion in annual revenue. There are 75 million CT scans in the world every year. 40 million MRI scans every year in the US. About 1 million cardiac cath lab procedures in the US every year. Those numbers grow every year. The amount of contrast media used worldwide roughly doubles every 10 years (mostly population growth but also improved access to medical facilities) therefore so do the scans. You can play with the numbers to come up with different scenarios but the revenue is there once DyeVert becomes the procedure of choice.
- Forums
- ASX - By Stock
- OSP
- Ann: GE Healthcare to Distribute Osprey Medical Technology
Ann: GE Healthcare to Distribute Osprey Medical Technology, page-246
-
- There are more pages in this discussion • 186 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online